Patent details
EP2026801 Title: Deferasirox for the treatment of hereditary hemochromatosis
Basic Information
- Publication number:
- EP2026801
- PCT Application Number:
- PCT/US/2007/069319
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078401908
- PCT Publication Number:
- WO/2008/005624
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Deferasirox for the treatment of hereditary hemochromatosis
- French Title of Invention:
- Déférasirox pour le traitement de l'hémochromatose héréditaire
- German Title of Invention:
- Deferasirox zur Behandlung ererbter Hämochromatose
- SPC Number:
Dates
- Filing date:
- 21/05/2007
- Grant date:
- 06/11/2013
- EP Publication Date:
- 06/11/2013
- PCT Publication Date:
- 10/01/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/02/2009
- EP B1 Publication Date:
- 06/11/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 21/05/2018
- Expiration date:
- 21/05/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/05/2007
- Name:
- Novartis AG
- Address:
- Corporate Intellectuel Property, CH-4002 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- ROJKJAER Lisa
- Address:
- United States (US)
2
- Name:
- BODNER Janet Ellen
- Address:
- United States (US)
3
- Name:
- NICK Hanspeter
- Address:
- Switzerland (CH)
4
- Name:
- MARKS Peter Wayne
- Address:
- United States (US)
Priority
1
- Priority Number:
- 747974 P
- Priority Date:
- 23/05/2006
- Priority Country:
- United States (US)
2
- Priority Number:
- 803049 P
- Priority Date:
- 24/05/2006
- Priority Country:
- United States (US)
3
- Priority Number:
- 835658 P
- Priority Date:
- 04/08/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/4196;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 08/05/2017
- Last Annual Fee Paid Number:
- 11
- Last Annual Fee Paid Amount:
- 148 Euro
- Payer:
- MARKS & CLERK LLP
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/09/2018 | Outgoing Correspondence | 1 |